MELISSA FROST: Open Payments
NPI 1518123900 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $517 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $63 |
| PFIZER INC. | 3 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| UCB, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $35 |
| LEO Pharma Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $26 |
| Journey Medical Corporation | 1 | $22 |
| Botanix SB Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: DUPIXENT, CIBINQO, Zoryve, Bimzelx, SKYRIZI, ADBRY, TREMFYA, SOFDRA.
Industry payments across CO — which companies pay providers there.
